Please Wait
Applying Filters...
menu
    • menu
    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Macimorelin

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    COSCIENS Secures Exclusive Macrilen Distribution Deal
    COSCIENS Secures Exclusive Macrilen Distribution Deal

    01 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/01/3197504/0/en/COSCIENS-Announces-Exclusive-Distribution-Agreement-with-Wuzhou-Drug-International-for-Macrilen-in-Hainan-Guangdong-Hong-Kong-Macao-Greater-Bay-Area-and-Singapore.html

    GLOBENEWSWIRE
    01 Dec 2025
    Share Share
    Aeterna Zentaris Provides Update on Macrilen (Macimorelin)
    Aeterna Zentaris Provides Update on Macrilen (Macimorelin)

    05 Apr 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/04/05/2641603/0/en/Aeterna-Zentaris-Provides-Update-on-Macrilen-Macimorelin-Reiterates-Advancement-of-Pediatric-DETECT-Trial.html

    GLOBENEWSWIRE
    05 Apr 2023
    Share Share
    Aeterna Zentaris Set to Regain Full Rights to Macrilen™ (Macimorelin)
    Aeterna Zentaris Set to Regain Full Rights to Macrilen™ (Macimorelin)

    29 Aug 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/08/29/2505902/0/en/Aeterna-Zentaris-Set-to-Regain-Full-Rights-to-Macrilen-Macimorelin-in-U-S-and-Canada-from-Novo-Nordisk.html

    GLOBENEWSWIRE
    29 Aug 2022
    Share Share
    AETERNA ZENTARIS ANNOUNCES ABSTRACT OF RESULTS FROM FIRST PEDIATRIC STUDY
    AETERNA ZENTARIS ANNOUNCES ABSTRACT OF RESULTS FROM FIRST PEDIATRIC STUDY

    30 Jul 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/07/30/2070270/0/en/AETERNA-ZENTARIS-ANNOUNCES-ABSTRACT-OF-RESULTS-FROM-FIRST-PEDIATRIC-STUDY-OF-MACIMORELIN-ACCEPTED-FOR-PRESENTATION-AT-THE-22ND-EUROPEAN-CONGRESS-OF-ENDOCRINOLOGY.html

    GLOBENEWSWIRE
    30 Jul 2020
    Share Share
    EMA committee recommends approval for 4 medicine
    EMA committee recommends approval for 4 medicine

    20 Nov 2018

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=112362&sid=2

    PHARMABIZ
    20 Nov 2018
    Share Share
    Meeting highlights from Committee for Medicinal Products for Human Use 12-15 Nov, 18
    Meeting highlights from Committee for Medicinal Products for Human Use 12-15 Nov, 18

    17 Nov 2018

    // EMA

    https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-12-15-november-2018

    EMA
    17 Nov 2018
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.